Tom Zydowsky is a senior scientist and head of pharmaceutical development in the HIV and AIDS program at the Population Council’s Center for Biomedical Research. He leads one of the Council’s team of scientists in the development of microbicides—substances that come in various forms and can be inserted into the vagina or rectum to protect against HIV and other sexually transmitted infections (STIs). He also leads the research to develop multi-purpose technologies (MPTs)—devices that deliver both microbicides and contraceptives.
Zydowsky received his PhD in organic chemistry from the University of Georgia and a certificate in regulatory writing from the University of the Sciences in Philadelphia. Following a National Institutes of Health fellowship with Heinz Floss and Leo Paquette at the Ohio State University, Zydowsky joined Abbott Laboratories, where he designed and synthesized renin inhibitors, angiotensin II antagonists, and nitric oxide synthase inhibitors. Before joining the Council in 2007, he also worked at Cubist Pharmaceuticals (anti-infectives), Shipley (semiconductor materials), Eisai Research Institute (GPCR inhibitors), and FMC Corporation (GABA inhibitors and muscarinic agonists). Zydowsky is also a freelance writer and specializes in biographies of influential chemists.